News

harnessing the
microbiome
microbiome
to transform lives
Press releases
Finch Therapeutics Presents Data from its Positive PRISM3 Trial of CP101 in Recurrent C. difficile Infection at Two Leading Medical Conferences
October 28, 2020Finch Therapeutics Announces $90 Million Financing to Advance Pipeline of Investigational Oral Microbiome Drugs
Sep 17, 2020Events & presentations
Microbiome Movement Drug Development Europe
Jan 28, 2021Chardan 3rd Annual Microbiome Medicines Summit
Mar 8, 2021